Historical Publications

2017:

  • Grossman PM, Ali SS, Aronow HD, Boros M, Nypaver TJ, Schreiber TL, Park YJ, Henke PK, Gurm HS. Contrast Induced Nephropathy in Patients Undergoing Endovascular Peripheral Vascular Intervention: Incidence, Risk Factors, and Outcomes as Observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Int Cardiol. March 2017. http://onlinelibrary.wiley.com/doi/10.1111/joic.12379/full
  • Thomas MP, Park J, Grey S, Schreiber TL, Gurm HS, Leffler D, Davis TP, Henke P, Grossman P. Temporal Trends in Peripheral Arterial Interventions: Observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 PVI). Catheter Cardiovasc Interv. March 2017. http://onlinelibrary.wiley.com/doi/10.1002/ccd.26883/full

2016:

  • Peter K. Henke, Yeo J. Park, Sachinder Hans, Paul Bove, Robert Cuff, Andris Kazmers, Theodore Schreiber, Hitinder S. Gurm, and P. Michael Grossman. The Association of Peri-Procedural Blood Transfusion and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC. PLoS ONE. November 2016. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165796

2015:

  • Brian M. Renard, Milan Seth, David Share, Herb Aronow, Eugene Laveroni, Michele De Gregorio, Sachinder S. Hans, Peter K. Henke, Hitinder S. Gurm, and P. Michael Grossman.  If Not Now, When? Prescription of Evidence-Based Medical Therapy Prior to Hospital Discharge Increases Utilization at 6 Months in Patients with Symptomatic Peripheral Artery Disease.  Vascular Medicine 1-7. August 2015. http://www.ncbi.nlm.nih.gov/pubmed/26324153
2014:
  • Venkat Krishnamurthy; Khan Munir; John E. Rectenwald; Ash Mansour; Sachinder Hans; Jonathan L. Eliason; Guillermo A. Escobar; Katherine A. Gallagher; Paul M. Grossman; Hitinder S. Gurm; Dave A. Share; Peter K. Henke. Contemporary Outcomes with Percutaneous Vascular Interventions for Peripheral Critical Limb Ischemia in Those with and without Poly-vascular Disease. Vascular Medicine, 1-9. Published online October 7, 2014. DOI: 10.1177/1358863X14552013 Retrieved from: http://vmj.sagepub.com/content/early/2014/10/04/1358863X14552013
  • Elizabeth A. Jackson, MD MPH; Khan Munir, PhD; Theodore Schreiber, MD; Jeffrey R. Rubin, MD; Robert Cuff, MD; Katherine A. Gallagher, MD; Peter K. Henke, MD; Hitinder S. Gurm, MD; P. Michael Grossman, MD. Impact of Gender on Morbidity and Mortality Rates Following Lower Extremity Interventions for Peripheral Arterial Disease: Observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol. Published online April 23, 2014. doi:10.1016/j.jacc.2014.03.036 http://mdlinx.pdr.net/cardiology/news-article.cfm/5233176/peripheral-arterial-disease-pad

2013:

  • Amer K. Ardati, MD, Bertram Pitt, MD, Dean E. Smith, PhD, MPH, Herbert D. Aronow, MD, MPH,  David Share, MD, Mauro Moscucci, MD, MBA, Stanley Chetcuti, MD, P. Michael Grossman, MD, Hitinder S.Gurm, MD. Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention. Am Heart J, 2013;0:1-7. http://www.ncbi.nlm.nih.gov/pubmed/23622915
  • Amneet Sandhu, MD; Mauro Moscucci, MD, MBA; Simon Dixon, MD; David Wohns, MD; David Share, MD, MPH; Thomas LaLonde, MD; Dean Smith, PhD; and Hitinder S. Gurm, MBBS. Differences in the outcome of patients undergoing percutaneous coronary interventions at teaching versus non-teaching hospitals. American Heart Journal, published August 1, 2013. http://www.ncbi.nlm.nih.gov/pubmed/24016486
  • Amneet Sandhu, MD; Milan Seth, MS; Simon Dixon, MD; David Share, MD, MPH; David Wohns, MD; Thomas LaLonde, MD; Mauro Moscucci, MD, MBA; Arthur L. Riba, MD; Michael Grossman, MD; Hitinder S. Gurm, MBBS. Contemporary Use of Prasugrel in Clinical Practice Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ Cardiovasc Qual Outcomes, published online May 14, 2013; http://www.ncbi.nlm.nih.gov/pubmed/23674313
  • Emily Perdoncin, Min Zhang, Arthur Riba, Thomas A. LaLonde, Cindy L. Grines and Hitinder S. Gurm. Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet Glycoprotein IIb/IIIa Inhibitors: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Circ Cardiovasc Interv December 2013. http://www.ncbi.nlm.nih.gov/pubmed/24280966
  • Hitinder S. Gurm, MD, Carrie Hosman, PhD, David Share, MD, Mauro Moscucci, MD, and Ben B. Hansen, PhD. Comparative Safety of Vascular Closure Devices and Manual Closure Among Patients Having Percutaneous Coronary Intervention. Ann Intern Med. November 2013;159:660-666. http://www.ncbi.nlm.nih.gov/pubmed/24247671
  • Hitinder S. Gurm, MD, Milan Seth, MS, Judith Kooiman, MSc, David Share, MD. A Novel Tool for Reliable and Accurate Prediction of Renal Complications in Patients Undergoing Percutaneous Coronary Intervention. JACC, June 4, 2013:2242–8. http://www.ncbi.nlm.nih.gov/pubmed/23721921
  • Hitinder S Gurm, MD; Dean Smith, PhD, MPH; David Share, MD; David Wohns, MD; John Collins MD; Mohan Madala, MD; Srinivas Koneru, MD; Dan Menees, MD; Stanley Chetcuti, MD. Impact of Automated Contrast Injector Systems on Contrast Use and Contrast Associated Complications in Patients Undergoing Percutaneous Coronary Interventions. JACC Cardiovasc Interv. April 2013. http://www.ncbi.nlm.nih.gov/pubmed/23523450
  • Javier A. Valle, MD; Min Zhang, Ph.D.; Simon Dixon, MBChB; Herbert D. Aronow, MD, MPH; David Share,MD, MPH; Joseph B. Naoum, MD; Hitinder S. Gurm, MBBS, Impact of Pre-Procedural Beta Blockade on Inpatient Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST elevation Myocardial Infarction American Journal of Cardiology. (To be published online, JACC Cardiovasc Interv. June 2013). http://www.ncbi.nlm.nih.gov/pubmed/23528025
  • John R. Hoyt, MD, Milan Seth, MS, Ivan Hanson, MD, Simon Dixon, MD, David Share, MD, MPH,Thomas Lalonde, MD, David Wohns, MD, Mauro Moscucci, MD, MBA, and Hitinder S. Gurm, MD. Outcome of Percutaneous Coronary Intervention following Recent Surgery. Am J Cardiol, 2013: http://www.ncbi.nlm.nih.gov/pubmed/23998350
  • Larsen GK, Seth M, Gurm HS., The Ongoing Importance of Smoking as a Powerful Risk Factor for ST-Segment Elevation Myocardial Infarction in Young Patients. JAMA Intern Med. 2013 May 27:1-2. doi: 10.1001/jamainternmed.2013.6075. http://www.ncbi.nlm.nih.gov/pubmed/23712862
  • Michael E. Buschur, MD; Dean Smith, PhD, MPH; David Share, MD; William Campbell, MD; Stephen Mattichak, MD; Manoj Sharma, MD; Hitinder S. Gurm, MD. The Burgeoning Epidemic of Morbid Obesity in Patients Undergoing Percutaneous Coronary Intervention: Insight From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. JACC, August 20, 2013:685–91. http://www.ncbi.nlm.nih.gov/pubmed/23948512
  • Mohamad Kenaan, MD, Milan Seth, MS, Herbert D. Aronow, MD, MPH, David Wohns, MD, David Share, MD, Hitinder S. Gurm, MD. The Clinical Outcomes of Percutaneous Coronary Intervention Performed Without Pre-Procedural Aspirin. JACC December 2013;62(22);2083-9. http://www.ncbi.nlm.nih.gov/pubmed/24055844
  • Sherezade Khambatta, DO, MHA, Milan Seth, MS,  Howard S. Rosman, MD, David Share, MD, MPH, Herbert D. Aronow, MD, MPH, FACC, Mauro Moscucci, MD, MBA, Thomas LaLonde, MD, Simon R. Dixon, MBChB, FACC, Hitinder S. Gurm, MD, FACC. The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J, 2013;0:1-9.e1. http://www.ncbi.nlm.nih.gov/pubmed/23708159

 

2012:

  • Amer K. Ardati, MD, Samuel R. Kaufman, MA, Herbert D. Aronow, MD, MPH, Timothy J. Nypaver, MD, Paul G. Bove, MD, Hitinder S. Gurm, MD, P. Michael Grossman, MD. The Quality and Impact of Risk Factor Control in Patients with Stable Claudication Presenting for Peripheral Vascular Interventions. Circulation Cardiovascular Interventions Dec 2012. http://www.ncbi.nlm.nih.gov/pubmed/23233746
  • Cause and Circumstance of In-Hospital Mortality Among Patients Undergoing Contemporary Percutaneous Coronary Intervention: A Root-Cause Analysis. Javier A. Valle, MD; Dean E. Smith, PhD, MPH; Anna M. Booher, MD; Daniel S. Menees, MD; Hitinder S. Gurm, MD. Circ Cardiovasc Qual Outcomes. 2012;5:00-00. http://www.ncbi.nlm.nih.gov/pubmed/22373903
  • Hitinder S. Gurm, MD, Dean E. Smith, PhD, MPH, Otavio Berwanger, MD, David Share, MD, Theodore Schreiber MD,  Mauro Moscucci, MD, MBA,  Brahmajee K. Nallamothu, MD, MPH, for  the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Contemporary use and effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2012 Jan;5(1):98-104. http://www.ncbi.nlm.nih.gov/pubmed/22230155
  • Javier Valle, Dean E. Smith, Stephen G. Ellis, Hitinder S Gurm, Eroding the denominator: the incomplete story of Door-to-Balloon Time Reporting. Research Letter; J Am Coll Cardiol, doi:10.1016/j.jacc.2012.02.047 (Published online 30 May 2012). http://www.ncbi.nlm.nih.gov/pubmed/22657268
  • Nicklaus K Slocum, MD, P Michael Grossman, MD,  Mauro Moscucci, MD, Dean E Smith, PhD, MPH, Herbert D. Aronow, MD, MPH, Simon R. Dixon, MBChB, David Share, MD, Hitinder S Gurm, MD, The Changing Definition of Contrast Induced Nephropathy and Its Clinical Implications: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J. 2012 May;163(5):829-34. PMID: 22607861. http://www.ncbi.nlm.nih.gov/pubmed/22607861

2011:

  • Benjamin R. Plaisance, MD, Khan Munir, PHD, David A. Share, MD, MPH, M. Ashraf Mansour, MD, James M. Fox, MD, Paul G. Bove, MD,Arthur L. Riba, MD, Stanley J. Chetcuti, MD,  Hitinder S. Gurm, MD, P. Michael Grossman, MD. Safety of Contemporary Percutaneous Peripheral Arterial Interventions in the Elderly Insights From the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) Registry. JACC:Cardiovascular Interventions, 2011 June: 4(6):694–701. Editorial Comment: JACC:Cardiovascular Interventions, 2011 June: 4(6):702-3. http://www.ncbi.nlm.nih.gov/pubmed/21700256
  • Brian J. Wheatley, MD; M. Ashraf Mansour, MD; P. Michael Grossman, MD; Khan Munir, MD; Robert F. Cali, MD; Jill M. Gorsuch, MD; Robert F. Cuff, MD; Peter Y. Wong, MD; Christopher M. Chambers, MD. Complication Rates for Percutaneous Lower Extremity Arterial Antegrade Access. Arch Surg. 2011 Apr;146 (4):432-5. http://www.ncbi.nlm.nih.gov/pubmed/21502451
  • Elizabeth A. Jackson, MD MPH, Mauro Moscucci, MD, MBA, Dean E. Smith, PhD, MPH, David Share, MD, Simon Dixon. MBChB, Adam Greenbaum, MD , Paul M. Grossman, MD, Hitinder S. Gurm, MD. The Association of Sex with Outcomes Among Patients Undergoing Primary PCI for STEMI In The Contemporary Era: Insights From The Blue Cross Blue Shield Of Michigan Cardiovascular Consortium (BMC2) Am Heart J. 2011;161:106-112.e1. http://www.ncbi.nlm.nih.gov/pubmed/21167341
  • Hitinder S. Gurm, MD, Simon R. Dixon, MBChB, Dean E. Smith, PhD, MPH, David Share, MD, Thomas LaLonde, MD, Adam Greenbaum, MD and Mauro Moscucci, MD, MBA,  for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry, Renal function based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. JACC. Vol. 58, No. 9, 2011:907–14. http://www.ncbi.nlm.nih.gov/pubmed/21851878
  • Michael P. Thomas, MD, Mauro Moscucci, MD, Dean E. Smith, PhD, MPH, Herb Aronow, MD, MPH,  David Share, MD, MPH, Phillip Kraft, MD, Hitinder S Gurm, MD. Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly; Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), Clinical Cardiology.  Clin Cardiol. 2011 Sep;34(9):549-54. http://experts.umich.edu/pubDetail.asp?n=Hitinder+S+Gurm&u_id=3444&oe_id=1&o_id=8&id=80052703605

2010:

  • Grossman, PM, Kaufman, SR, Share, DS, Aronow, HD, Chetcuti, SJ, Bove, P, Nypaver, TJ, Fox, JM, Mansour, MA, Gurm, HS. Does Location Matter? Improvement in Quality of Life for Patients Undergoing Percutaneous Vascular Interventions: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Card, March 9, 2010; 55:180A. http://content.onlinejacc.org/article.aspx?articleid=1142261
  • Kasapis C, Gurm HS, Chetcuit SJ, Munir K, Luciano A, Smith DE, Aronow HD, Kassab EH, Knox MF, Moscucci M, Share D, Grossman PM.  Defining the Optimal Degree of Heparin Anticoagulation for Peripheral Vascular Interventions:  Insight from a Large Regional Multicenter Registry.  Circ Cardiovasc Interv. 2010 Dec:3(6):593-601. http://www.ncbi.nlm.nih.gov/pubmed/21062999
  • Anneliese Flynn, MD; Mauro Moscucci, MD, MBA; David Share, MD, MPH; Dean Smith, PhD, MPH; Thomas LaLonde, MD; Hameem Changezi, MD; Arthur Riba, MD; Hitinder S. Gurm, MBBS  Trends in Door to Balloon Time and Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Arch Intern Med. 2010;170(20):1842-1849. http://www.ncbi.nlm.nih.gov/pubmed/21059978
  • Claire S. Duvernoy, MD, Dean E Smith, PhD, MPH,  Prerana Manohar, MD, Ann Schaefer, MS, RN, Eva Kline-Rogers, MS, RNP, David Share, MD, MPH, Richard McNamara, MD, Hitinder S. Gurm, MD, Mauro Moscucci, MD, MBA. Gender Differences in Adverse Outcomes Following Contemporary PCI: An Analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Percutaneous Coronary Intervention RegistryAm Heart J. 2010 Apr; 159(4):677-683.e1. http://www.ncbi.nlm.nih.gov/pubmed/20362729
  • Gualano SK, Gurm HS, Share D, Smith DE, Aronow HD, Lalonde T, Bates ER, Changezi H, McNamara R, Moscucci M.  Temporal Trends in the Use of Drug-eluting Stents for Approved and Off-label Indications:  A Longitudinal Analysis of a Large Multicenter Percutaneous Coronary Intervention RegistryClin. Cardiol, 33, 2, 111-116, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20186993
  • Krishna G. Aragam, AB, Mauro Moscucci, MD, MBA, Dean E. Smith, PhD, Arthur L. Riba, MD, Mark Zainea, MD, James L. Chambers, MD, David Share, MD, Hitinder S. Gurm, MBBS.  Trends and Disparities in Referral to Cardiac Rehabilitation After Percutaneous Coronary Intervention. Am Heart J. 2010;0:1-8.e2. http://www.ncbi.nlm.nih.gov/pubmed/21392610
  • Reed MC, Moscucci M, Smith DE, Share D, LaLonde T, Mahmood SA, D’Haem C, McNamara R, Greenbaum A, Gurm HS. The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Journal of Invasive Cardiology, 2010;22:467–472. http://www.ncbi.nlm.nih.gov/pubmed/20944185
  • Santi Trimarchi, MD, Dean E. Smith, PhD, David Share, MD, MPH, Sandeep M. Jani, MPH, Michael O'Donnell, MD, FACC, Richard McNamara, MD, FACC, Arthur Riba, MD,FACC,  Eva Kline-Rogers, RN, Hitinder S. Gurm, M.D., FACC, Mauro Moscucci, MD, FACC†.  Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes and Predictors of Mortality. A report From The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry.  J. Am. Coll. Cardiol. Intv. 2010; 3; 845-850. http://www.ncbi.nlm.nih.gov/pubmed/2072385

2009:

  • Grossman PM, Gurm HS,  McNamara R, Lalonde T, Changezi H, Share D, Smith DE, Chetcuti SJ, Moscucci M.  Percutaneous Coronary Intervention Complications and Guide Catheter Size: Bigger is Not Better.  JACC Interventions, 2009; 2 (7):636-44. http://www.ncbi.nlm.nih.gov/pubmed/19628187

2008:

  • Gurm HS, Smith DE, Collins SJ, Share D, Riba A, Carter AJ, LaLonde T, Kline-Rogers EM, O’Donnell M, Changezi H, Zughaib M, Safian R, and Moscucci M.  The Relative Safety and Efficacy of Abciximab and Eptifibatide in Patients Undergoing Primary Percutaneous Coronary Intervention:  Insights From A Large Regional Registry of Contemporary Percutaneous Coronary InterventionJ Amer Coll Card., 2008; 51 (5): 529-535. http://www.ncbi.nlm.nih.gov/pubmed/18237680

2007:

  • Chetcuti SJ, Grossman PM, Kline-Rogers EM, Montoye C, Smith DE and Moscucci M.  Improving Outcomes of Percutaneous Coronary Intervention through the Application of Guidelines and Benchmarking:  Reduction of Major Bleeding and Blood Transfusion as a Model.  Clin. Cardiol., 2007; 30 (Suppl. II), II-44 – II-48. http://www.ncbi.nlm.nih.gov/pubmed/18228651
  • Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, LaLonde T, Kline-Rogers EM, O’Donnell M, O’Neill WO, Safian R, and Moscucci M.  Temporal Trends, Safety, and Efficacy of Bivalirudin in Elective Percutaneous Coronary Intervention:  Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.  J Interven Cardio., 2007; 20: 197-203. http://www.ncbi.nlm.nih.gov/pubmed/17524111
  • Jani SM, Smith DE, Share DM, Kline-Rogers EM, Khanal S, O'Donnell M, Gardin J, and Moscucci M.  Blood Transfusion and In-Hospital Outcomes in Anemic Patients with Myocardial Infarction Undergoing Percutaneous Coronary Intervention.   Clin. Cardiol. 2007; 30 (Suppl. II): II-49 – II-56. http://www.ncbi.nlm.nih.gov/pubmed/18228652

2006:

  • Lins S, RN, Guffey D, RN, Kline-Rogers E, MS, RN, VanRiper S, MS, RN. Decreasing Vascular Complications following Percutaneous Coronary Interventions: Partnering to improve outcomes.  Critical Care Nurse, 2006;26 (6): 38-45. http://www.ncbi.nlm.nih.gov/pubmed/17123950
  • Moscucci M, MD, Kline Rogers E, RN, MS, Montoye C, RN, MN, Smith DE, MS, PhD, Share D, MD, MPH, O’Donnell M, MD, Maxwell-Eward A, PhD, Meengs WL, MD, De Franco AC, MD, Chambers JL, MD, Patel K, MD, McGinnity JG, MS, PA-C, Khanal S, MD, Eagle KA, MD, For the Blue Cross Blue Shield of Michigan  Cardiovascular Consortium (BMC2).  Association of a Continuous Quality Improvement Initiative With Practice and Outcome Variations of Contemporary Percutaneous Coronary Interventions.  Circulation, 2006;113:814-822. http://www.ncbi.nlm.nih.gov/pubmed/16461821

2005:

  • Mukherjee D, Munir K, Hirsch AT, Chetcuti S, Grossman PM, Rajagopalan S, Nallamothu BK, Moscucci M, Henke P, Kassab E, Sohal C, Riba A, Person D, Luciano AE, DeGregorio M, Patel K, Rutkowski KC, Eagle KA. Development of a Multicenter Peripheral Arterial Interventional Database: The PVD-QI2. Am Heart J. 2005 Jun; 149(6):1003-1008. http://www.ncbi.nlm.nih.gov/pubmed/15976781
  • Aboufakher R, MDa, Riba A, MDa, Jani SM, BSb, Goswami R, MDa, Shwartz S, PhDa, Lins S, RNa, Gardin Jc, Smith DE, MS, PhDb, Kline-Rogers E, RN, MSb, Share D, MD, MPHd, Moscucci M, MDb, for The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), University of Michigan Medical Center, Ann Arbor, MI.  Incidence, Risk Factors and Prognosis of Congestive Heart Failure after Percutaneous Coronary Intervention – Insights from the Blue Cross/Blue Shield of Michigan Cardiovascular Consortium (BMC2)Am Heart J 2005;150:455-8.
  • Moscucci M, MD, Eagle KA, MD, Share D, MD, MPH, Smith DE, PhD, De Franco AC, MD, Vakili BA, MD, Clark VL, MD, Slater JN, MD, Sherman W, MD, Ravi KL, MD, Sanborn TA, MD, Green SJ, MD, Brown DL, MD.  University of Michigan Health System (MM, KAE); Blue Cross Blue Shield Center for Health Care Quality (DS); McLaren Regional Medical Center (ACD); Henry Ford Hospital (VLC); Albert Einstein College of Medicine/Montefiore Medical Center.  Public Reporting and Case Selection for Percutaneous Coronary Interventions: An Analysis from Two Large Multicenter PCI Databases.  J Am Coll Cardiol  2005;45:1759-65. http://www.ncbi.nlm.nih.gov/pubmed/15936602
  • Moscucci M, MD, Smith DE, PhD, DeFranco AC, MD, O'Donnell MJ, MD, Meengs WL, MD, Maxwell-Eward A, PhD, McGinnity JG, Patel K, MD, Share D, MPH, MD, Eagle KA, M.D.  Relationship Between Operator Volume and Adverse Outcome In Contemporary Percutaneous Coronary Intervention Practice:  An Analysis of a Quality Controlled Multicenter Percutaneous Coronary Intervention Clinical DatabaseJ Am Coll Cardiol 2005;46:625-32. http://www.ncbi.nlm.nih.gov/pubmed/16098426

2004:

  • McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, Meengs WL, McNamara R, McGinnity JG, Patel K, Share D, Riba A, Khanal S, Moscucci M, for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Prognostic Implication of Anemia on In-Hospital Outcomes after Percutaneous Coronary Intervention.  Circulation. 110(3):271-7, 2004. http://www.ncbi.nlm.nih.gov/pubmed/15226214
  • Mukherjee D, Fang F, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KE, Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes. Circulation. 109:745-749, 2004. http://www.ncbi.nlm.nih.gov/pubmed/14970110

2003:

  • Moscucci M, O’Donnell M, Share D, Maxwell-Eward A, Kline-Rogers E, DeFranco AC, Meengs, WL, Clark VL, McGinnity JG, DeGregorio M, Patel K, Eagle KE.  Frequency and Prognosis of Emergency Coronary Artery Bypass Grafting After Percutaneous Coronary Intervention for Acute Myocardial Infarction. American Journal of Cardiology. 92:967-969, 2003. http://www.ncbi.nlm.nih.gov/pubmed/14556874
  • Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM, Nallamothu B, O’Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J, Meengs WL, Patel K, Moscucci M on behalf of the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium (BMC2).  Impact of Extracardiac Vascular Disease on Acute Prognosis in Patients who Undergo Percutaneous Coronary Interventions (Data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium ([BMC2).  American Journal of Cardiology. 92:972-974, 2003. http://www.ncbi.nlm.nih.gov/pubmed/14556876

2002:

  • Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, Eagle KA. Missed Opportunities to Treat Atherosclerosis in Patients Undergoing Peripheral Vascular Interventions: Insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 2002; 106:1909-12. http://www.ncbi.nlm.nih.gov/pubmed/12370211
  • Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M.  The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).  Nephropathy Requiring Dialysis after Percutaneous Coronary Intervention and the Critical Role of an Adjusted Contrast Dose.  American  Journal of  Cardiology, 90:1068-1073, 2002. http://www.ncbi.nlm.nih.gov/pubmed/12423705
  • Kline-Rogers E, Share D, Bondie D, Rogers B, Karavite D, Kanten S, Wren P, Bodurka C, Fisk C, McGinnity J, Wright S, Lucarelli C, Eagle, KA, Moscucci M, for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).  Development of a Multi-Center Interventional Cardiology Database: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Experience. J Interven Cardiol, 15:387-392, 2002. http://www.ncbi.nlm.nih.gov/pubmed/12440182
  • Moscucci M, Share D, Kline-Rogers E, O’Donnell M, Maxwell-Eward A, Meengs WL, Clark V, Kraft P, De Franco AC, Chambers JL, Patel K, McGinnity JG, Eagle K, for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).  The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Collaborative Quality Improvement Initiative in Percutaneous Coronary Interventions. J Interventional Cardiology, 15:381-386, 2002. http://www.ncbi.nlm.nih.gov/pubmed/12440181

2001:

  • Moscucci M, Share D, Kline-Rogers E, O’Donnel MO, Maxwell-Eward A, Meengs WL, Chambers JL, Kraft P, DeFranco AC, Chambers JL, Patel K, McGinnity JG, Eagle KA.  Simple Bedside Additive Tool for Prediction of In-Hospital Mortality after Percutaneous Coronary Interventions. Circulation, 104:263-268, 2001. http://www.ncbi.nlm.nih.gov/pubmed/11457742

1999:

  • Moscucci M, O’Connor GT, Ellis SG, Malenka DJ, Sievers J, Bates ER, Muller DWM, Werns SW, Kline-Rogers E, Karavite D, Eagle KA.  Validation of Risk Adjustment Models for In-Hospital Percutaneous Transluminal Coronary Angioplasty Mortality on an Independent Data Set.  JACC Vol 34., no 3, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10483949

1998:

  • Moscucci M, Ricciardi M, Eagle KA, Kline-Rogers E, Bates ER, Werns SW, Karavite D, Muller DWM.  Frequency, Predictors, and Appropriateness of Blood Transfusion After Percutaneous Coronary Interventions.  Am J Cardiol 1998; 81:702-707. http://www.ncbi.nlm.nih.gov/pubmed/9527078